AlphAIAlphAI — Financial news for AI agents
tradingview.comNOV 31 min read$CRVL

CorVel Corporation (CRVL) Q2 Revenue Rose to $267M and EPS to $0.67

CorVel Corporation (CRVL) reported Q2 2026 revenue of $267M, up from $240M a year earlier, and EPS of $0.67, up from $0.54. For the first six months, revenue was $527M, up from $474M, and EPS was $1.31, up from $1.06. The company's performance showed growth compared to the prior-year periods.

Original reporting
tradingview.com
Published Nov 3, 2026, 11:15 AM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Nov 3, 2026, 11:19 AM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
About AlphAI AI DeskScoring methodologyReport an issue
CorVel Corporation (CRVL) Q2 Revenue Rose to $267M and EPS to $0.67 — source image
Source · tradingview.com
Decision brief

The 30-second read

$CRVLBullishHigh
01

Why it matters

The earnings beat prior-year numbers, providing a fresh catalyst for traders.

02

Market read

First‑time earnings data for CRVL, likely to move the stock.

03

What to watch

Potential impact of upcoming regulatory changes in healthcare reimbursement.

Relevance 8/10Novelty 8/10Timing: pre‑market today

Background

CorVel Corporation filed its Q2 2026 earnings press release via GlobeNewswire.

Company-level read

Ticker impact

$CRVLBullishHigh confidence
Context

Q2 2026 earnings released with revenue $267M and EPS $0.67, up from prior year.

Expected impact

likely upward pressure as market prices in better-than-year performance

Evidence & confidence

First report of quarterly results shows revenue and EPS growth, a material positive catalyst for a mid‑cap stock.

Market effects

Sector

Improves outlook for the healthcare services sector.

Regional

Positive for U.S. mid‑cap equities.

Global

Limited to U.S. markets.

Counterpoint

What could challenge this read

If guidance is weak or costs rise, the rally could be short‑lived.

Key entities

  • Company
    CorVel Corporation

    Provider of healthcare solutions, ticker CRVL.

Read at source← All news

StoryCorVel posts 24% EPS rise to $0.67 on 11% revenue growth in Q2 FY2027

Also covered by

1 outlet

Related articles

NOV 3
$CRVLHigh

CorVel Announces Revenues and Earnings

CORVEL CORP (CRVL) filed an SEC Form 8-K — Results of Operations and Financial Condition. Exhibit 99.1 Date: November 3, 2026 CorVel Corporation 5128 Apache Plume Road Suite 400 Fort Worth, TX 76109 FOR IMMEDIATE RELEASE Contact: Melissa Storan Phone: 949-851-1473 www.corvel.com CorVel Announces Revenues and Earnings FORT WORTH, Texas, November 3, 2026 — CorVel Corpor

SEC EDGAR 8-K2 min
AUG 5
$CRVLMedAI 8/10

CorVel Corp.: CorVel Announces Revenues and Earnings

CorVel Corporation (NASDAQ: CRVL) reported quarterly results for the quarter ended June 30, 2026. Revenues rose to $259.9 million from $234.7 million a year earlier. Diluted EPS increased to $0.63 from $0.52. The company ended the quarter with $255.9 million in cash and no borrowings, and repurchased $21.8 million of common stock.

finanznachrichten.de4 min
AUG 4
$CRVLMed

CorVel Announces Revenues and Earnings

CORVEL CORP (CRVL) filed an SEC Form 8-K — Results of Operations and Financial Condition. Exhibit 99.1 Date: August 5, 2026 CorVel Corporation 5128 Apache Plume Road Suite 400 Fort Worth, TX 76109 FOR IMMEDIATE RELEASE Contact: Melissa Storan Phone: 949-851-1473 www.corvel.com CorVel Announces Revenues and Earnings FORT WORTH, Texas, August 5, 2026 — CorVel Corporatio

SEC EDGAR 8-K6 min
JUN 1
$CRVLMed

CorVel Appoints Sarah Scott CEO and President; Michael G. Combs to Transition to Executive Chair

CorVel announced that Sarah Scott will become CEO and President effective July 1, 2026, replacing Michael G. Combs, who will move to Executive Chair. CorVel said Combs led as President since 2017 and CEO since 2019, and will advise Scott during the transition. Scott has been with the company for over 26 years, currently serving as Executive VP, Product and Corporate Services.

manilatimes.net3 min
NOV 3
$SBUXMed

Why Morgan Stanley sees customers spending more at Starbucks

Morgan Stanley raised its 12-18 month price target for Starbucks (SBUX) to $116 from $115 after Q4 results showed a 5.2% increase in U.S. average spend per visit and 2.4% customer growth. Adjusted operating margin expanded 450 basis points year over year to 14.0%, beating expectations. SBUX shares closed at $103.67 on Oct. 30, up 23% year to date. The company's adjusted earnings per share hit $0.80, surpassing Wall Street's $0.72 estimate.

finance.yahoo.com2 min